Loading...
NPI 1942221098 · Baton Rouge, LA · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Louisiana Department Of Health - Office Of Public Health is a clinical medical laboratory provider located in Baton Rouge, Louisiana. This profile covers 3 Medicare and 50 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Louisiana Department Of Health - Office Of Public Health |
| Address | 1209 Leesville Ave |
| City | Baton Rouge |
| State | LA |
| ZIP | 70802 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | July 22, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $37.9M |
| Medicare | $16.3K |
Medicaid dominates this provider’s billing footprint: total Medicaid revenue is $37.9M compared with total Medicare revenue of $16.3K, indicating the operation is effectively a Medicaid-focused laboratory rather than a Medicare-facing revenue center. The scale difference suggests primary contracts and workflows are oriented to state public-health programs and population-level testing rather than fee-for-service Medicare markets.
Medicare revenue is extremely concentrated: the precomputed top 3 Medicare codes account for 100.0% of this provider's total Medicare revenue, driven by 87811 ($8.2K, 50.1%), 87491 ($4.1K, 25.1%), and 87591 ($4K, 24.8%). Despite these codes appearing on Medicare claims, the absolute Medicare dollars are small ($16.3K total), which implies a very limited Medicare patient volume or Medicare billing footprint for the lab.
Medicaid revenue is more distributed across programmatic testing: the precomputed top 3 Medicaid codes account for 29.5% of this provider's total Medicaid revenue, with 87591 ($3.8M, 10.0%), 87491 ($3.8M, 10.0%), and 82775 ($3.6M, 9.5%) among the highest single-code contributions. Because the top three capture under one-third of Medicaid revenue, a broad mix of other high-volume assays contributes materially to the $37.9M Medicaid total.
The code mix and claim volumes indicate a state public-health laboratory and newborn-screening hub: very large claim counts such as 223.8K claims for 82775 ($3.6M) and 223.1K claims for 83789 ($3.6M), plus high-volume neonatal and metabolic assays (e.g., 84437, 83498, 83021), point to population-level newborn and specialty testing services rather than episodic clinical lab work. Multiple high-volume, low-unit-pay codes consistent with newborn screening and mass spectrometry workflows reinforce that this is a centralized public-health testing operation.
Competitive standing within Louisiana is dominant for many Medicaid codes: multiple assays rank #1 in-state (for example, 87591 is #1 of 189 providers and 87491 is #1 of 194 providers, both labeled "extreme outlier, far above typical state volume for this code"), and other assays such as 83021, 83498, and 86318 also rank at the top statewide. These rank/percentile annotations and repeated #1 placements indicate the provider functions as the principal in-state laboratory for a wide set of Medicaid-covered tests.
Medicare competitive posture is modest despite some high percentiles: 87811 ranks #181 of 10132 providers nationally (98th percentile) but the Medicare revenue tied to these codes totals only $16.3K, so national rank for a given code does not translate into meaningful Medicare revenue contribution. The labels on the Medicare code entries (e.g., "typical, unremarkable volume for this code") combined with the small absolute Medicare dollars signal that Medicare is not a material revenue channel for this lab.
The provider performs substantial infectious-disease and public-health surveillance testing alongside newborn screening: notable Medicaid volumes and revenues include U0003 (36.4K claims, $2.6M, ranks #9 of 97 in-state) and U0005 (20.4K claims, $285.1K, ranks #5 of 54 in-state), while 87811 appears on both payers (Medicare: $8.2K; Medicaid: 4.3K claims, $116.6K). These entries show COVID-era and other infectious-agent testing are significant program components but do not eclipse the large newborn/metabolic screening throughput in Medicaid.
Long operational tenure supports the role as an established state testing hub: the NPI was enumerated on 2006-07-22 (~20 years ago), consistent with the sustained, high-volume Medicaid claim counts and the catalog of specialized assays. The combination of long tenure, statewide #1 rankings on many assays, and a Medicaid-centric revenue base aligns with a centralized public-health laboratory model rather than a small private clinical lab.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
3 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 87811 | The lab analyst performs the technical lab test to analyze for the presence of severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2) (Coronavirus disease [COVID–19]) in a specimen by… | 200 | $40 | $8.2K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 120 | $30 | $4.1K |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 120 | $30 | $4K |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 3 CPT/HCPCS codes.
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
50 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 117,730 | $30 | $3.8M |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 117,590 | $30 | $3.8M |
| 82775 | The lab analyst measures the amount of galactose–1–phosphate uridyl transferase in a blood sample, usually following a positive newborn screen that shows an abnormal result, or to monitor compliance… | 223,760 | $20 | $3.6M |
| 83789 | The lab analyst performs the technical lab test to evaluate the specimen for the presence or amount of a nondrug analyte by using mass spectrometry and tandem mass spectrometry. | 223,070 | $20 | $3.6M |
| 84143 | The lab analyst performs a test to evaluate the level of 17 hydroxypregnenolone in a patient specimen, such as serum. | 190,090 | $20 | $3.4M |
| 82261 | The lab analyst performs a measurement of the enzyme biotinidase, typically on a blood sample. This enzyme test is useful for the identification of a deficiency of biotinidase and also for the… | 223,570 | $10 | $3.1M |
| 83021 | The lab analyst measures and calculates the hemoglobin fractions in a whole blood sample demonstrated by this hemoglobin fractionation test by chromatography. | 223,240 | $10 | $3.1M |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 226,130 | $10 | $2.9M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 36,430 | $70 | $2.6M |
| 83516 | The lab analyst performs the technical immunoassay test involving several steps to detect and measure an analyte of a noninfectious nature. The results show as positive or negative, or in… | 223,650 | $10 | $2M |
Showing 1–10 of 50
How this provider's Medicaid billing volume and revenue compare to other Louisiana providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Louisiana median
50 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 82775 | The lab analyst measures the amount of galactose–1–phosphate uridyl transferase in a blood sample, usually following a positive newborn screen that shows an abnormal result, or to monitor compliance… | 1 | 10 | 223,760 | $20 | $3.7M |
| 84143 | The lab analyst performs a test to evaluate the level of 17 hydroxypregnenolone in a patient specimen, such as serum. | 1 | 10 | 95,060 | $20 | $1.7M |
| 82261 | The lab analyst performs a measurement of the enzyme biotinidase, typically on a blood sample. This enzyme test is useful for the identification of a deficiency of biotinidase and also for the… | 1 | 10 | 111,790 | $10 | $1.6M |
| 83789 | The lab analyst performs the technical lab test to evaluate the specimen for the presence or amount of a nondrug analyte by using mass spectrometry and tandem mass spectrometry. | 1 | 10 | 450 | $20 | $1.2M |
| 84437 | The lab analyst performs a test to measure thyroxine in specimens that require elution, which is washing whole blood from an absorbent material using a solvent, typically in whole blood neonatal… | 1 | 10 | 223,670 | $10 | $1.1M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 9 | 100 | 620 | $40 | $560K |
| 81479 | Use 81479 to report a molecular pathology procedure that does not have a specific code. | 1 | 10 | 60 | $10 | $217.4K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 2,196 | 3,230 | 1,120 | $30 | $204.3K |
| 83021 | The lab analyst measures and calculates the hemoglobin fractions in a whole blood sample demonstrated by this hemoglobin fractionation test by chromatography. | 1 | 20 | 160 | $10 | $140.7K |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 1 | 190 | 1,000 | $30 | $139.9K |
Showing 1–10 of 50
Other providers in the same ZIP code as Louisiana Department Of Health - Office Of Public Health, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Pcp Urgent Care Holdings LLC | LA | Urgent Care Clinic/Center | $0 | $24.5M |
| We Care Homes Inc | LA | Personal Care Attendant | $0 | $13M |
| Baton Rouge Area Alcohol & Drug Center, Inc. | LA | Substance Abuse Rehabilitation Facility | $0 | $8.4M |
| O'brien House | LA | Substance Abuse Rehabilitation Facility | $0 | $7.6M |
| Vonnieab's Respite Care, Inc. | LA | Home Health Agency | $0 | $5.5M |
| We Care Homes, Inc | LA | Child Intellectual and/or Developmental Disabilities Respite Care | $0 | $4.8M |
| Carmen Spooner | LA | Clinical Social Worker | $19.4K | $9.6K |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.